Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-K, Date: 2012-03-14, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: CPHI/20120314/10-K/1/000.htm SEC Original: cphi10k123111.htm
FORM 10-K x For the fiscal year ended December 31, 2011 or For the transition period from _________ to _____________ 001-34471 China Pharmas, Delaware 73-1564807 (State or other jurisdiction oforporation or organization) (IRS Employer Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 (011) 86 898-6681-1730

---

---

Webplus: CPHI/20120314/10-K/5_EX-23.1/000.htm SEC Original: cphi10kex231123111.htm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Wensent to theorporation by reference in Registration Statement No. 333-164049 on Form S-3 and Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our reportted March 14, 2012 relating to thensolidated financial statements of China Pharmas, and subsidiaries appearing in this Annual

---

---

Webplus: CPHI/20120314/10-K/6_EX-31.1/000.htm SEC Original: cphi10kex311123111.htm
CERTIFICATION (Section 302 of therbanes-Oxley Act of 2002) I, Zhilin Li, certify that: 1. I have reviewed this Annual Report on Form 10-K of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,

---

---

Webplus: CPHI/20120314/10-K/7_EX-31.2/000.htm SEC Original: cphi10kex312123111.htm
CERTIFICATION (Section 302 of therbanes-Oxley Act of 2002) I, Frank Waung, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b. Frank Waung Chief Financial Officer (principal financial officer and principal accountingofficer) cphi10kex312123111.htm 7 EX-31.2

---

---

Webplus: CPHI/20120314/10-K/8_EX-32.1/000.htm SEC Original: cphi10kex321123111.htm
CERTIFICATION (Section 906 of therbanes-Oxley Act of 2002) (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. s/ Zhilin Li / Zhilin Li cphi10kex321123111.htm 8 EX-32.1

---

---

Webplus: CPHI/20120314/10-K/9_EX-32.2/000.htm SEC Original: cphi10kex322123111.htm
CERTIFICATION (Section 906 of therbanes-Oxley Act of 2002) (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) cphi10kex322123111.htm 9 EX-32.2

---

Company Information:

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-K, Date: 2012-03-14, XBRL Interactive FinancialsCIK: 0001106644, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
2ND FLOOR, NO. 17, JINPAN ROAD, HAIKOU
HAINAN PROVINCE 570216